Xencor | XNCR - EPS Earnings Per Share


Xencor reported $-0.29 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 -0.78 -0.08 Nov/09
FY2026Q2 Jun/2026 -0.29 -0.80 -0.41 Aug/05
FY2026Q1 Mar/2026 -1.71 -0.66 -0.66 May/06
FY2025Q4 Dec/2025 -0.09 -0.6 -0.62 Feb/25
FY2025Q3 Sep/2025 -0.08 -0.69 -0.71 Nov/05




Eps Change Date
AbbVie USD 3.65 1 Jun/2026
Alnylam Pharmaceuticals USD 1.84 0.15 Jun/2026
Amgen USD 6.29 1.14 Jun/2026
Arrowhead Research USD -1.36 0.43 Jun/2026
AstraZeneca USD 2.63 0.05 Jun/2026
Biogen USD 3.6 0.03 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Cytokinetics USD -1.5 0.17 Jun/2026
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
J&J USD 2.9 0.2 Jun/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
MacroGenics USD -0.58 0.36 Mar/2026
Merck USD -0.13 1.15 Jun/2026
Novartis USD 2.41 0.42 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Xencor USD -0.29 1.42 Jun/2026